Aspen Pharmacare Holdings Ltd (JSE:APN)
R 244.27 -2.73 (-1.11%) Market Cap: 108.51 Bil Enterprise Value: 133.03 Bil PE Ratio: 22.29 PB Ratio: 1.27 GF Score: 85/100

Aspen Pharmacare Holdings Ltd Aspen Confirms Non-Binding Term Sheet on Manufacture And Sale of an Aspen Branded COVID-19 vaccine Throughout Africa Call Transcript

Nov 30, 2021 / 01:30PM GMT
Release Date Price: R238.26 (+6.26%)
Stavros Nicolaou
Aspen Pharmacare Holdings Limited - Group Senior Executive of Strategic Trade

Will commence the media briefing.

Stephen Bradley Saad
Aspen Pharmacare Holdings Limited - Group CEO & Executive Director

Stav, I think we should start.

Stavros Nicolaou
Aspen Pharmacare Holdings Limited - Group Senior Executive of Strategic Trade

Steve, it's rising quite rapidly here. We're on to 113 participants. Okay. So I think let's kick off. Colleagues, distinguished panelists, members of the media, good afternoon. And if you're dialing out of the North Americas, good morning. Thanks very much to all of you for making this Aspen media briefing today.

Today, we will be announcing a nonbinding term sheet between Aspen and Johnson & Johnson for the manufacturing and sale of an Aspen-branded COVID-19 vaccine for the African continent. This is indeed a monumental and groundbreaking development. It's groundbreaking for the African continent, its health care systems and also a significant step for the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot